Aarey Drugs & Pharmaceuticals allots ₹5.5 crore warrants
Aarey Drugs & Pharmaceuticals (AAREYDRUGS) said it has allotted warrants of ₹5.5 crore. The company is valued at about ₹335 crore.
What happened
In a filing with the BSE on 7 October 2026 at 03:00 PM, Aarey Drugs & Pharmaceuticals (AAREYDRUGS) said that it has allotted warrants of ₹5.5 crore.
From the filing: "SEBI/HO/CFD/PoD2/CIR/P/0155 dated November 11, 2024 ("SEBI Disclosure Circular"), the detailed disclosure in respect of the allotment of equity shares pu rsuant to conversion of warrants is set out below at Annexure - A."
How big is it?
At ₹5.5 crore, the issue is equal to about 1.6% of the company's market value of ₹335 crore.
Company snapshot
Aarey Drugs & Pharmaceuticals is a micro-cap company, with a market value of about ₹335 crore.
The stock last traded at ₹108.6, against a 52-week range of ₹50.31–₹110 (1.2% below the high).
Before this filing the shares had moved +12.6% over the month and +25.1% over three months. Average daily turnover over the last 20 sessions was about ₹2.41 crore.
Promoters held 42.79% at the end of Q2 FY27, up 5.08% points from the previous quarter. Foreign institutions owned 4.41% and domestic institutions 1.49%.
| Quarter | Revenue | Net profit | EPS (₹) |
|---|---|---|---|
| Q1 FY26 | 102 | 1.4 | 0.48 |
| Q2 FY26 | 84 | 1 | 0.72 |
| Q3 FY26 | 96 | 1.3 | 0.2 |
| Q4 FY26 | 189 | 1.6 | 0.55 |
| Q1 FY27 | 45 | 1 | 0.36 |
What history shows
BCEIE's records show 1 previous fund raising filing from the company since May 2026.
Market-wide, 1,515 fund raising filings with an impact score of 50 or more saw an average next-day move of +0.4%, with 48% rising.
Past reactions describe what happened before; they are not a forecast.
What to watch
- How the money raised is used and, for equity instruments, the dilution for existing shareholders.
In the news
Recent coverage elsewhere (links open the original publisher):
- Aarey Drugs & Pharmaceuticals Ltd. Upper Circuit: Price and Key Data
- Aarey Drugs AGM passes all resolutions with near-unanimous support
- Aarey Drugs promoter group stake rises to 41.45% via warrant conversion
- Warrant Conversion Boosts Non-Promoter Stake in Aarey Drugs & Pharmaceuticals
- Aarey Drugs & Pharmaceuticals Promoter Boosts Stake via Warrant Conversion
Source
Automatically written from the exchange filing and BCEIE data. Not investment advice. Check the original filing before acting on it.